×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Tau tangles and the evolving landscape of Alzheimer's research
Abcam
Learn how tau tangles drive Alzheimer's disease and explore tools and therapies shaping the future of tau research.
10 hours ago
Alzheimer’s disease biomarkers from discovery to diagnostic panels
Abcam
Yet most diagnoses still occur only after cognitive decline becomes noticeable and irreversible. Biomarkers are reshaping that reality.
2 days ago
How Abcam is leading the way in antibody performance
Abcam
Since 2020, Abcam has been working with an independent open-science organization, YCharOS (pronounced 'Icarus'), to verify the quality and consistency of...
2 months ago
Danaher to acquire Abcam for $24.00 per share
Abcam
Danaher Corporation (NYSE: DHR) ('Danaher') will acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the 'Transaction').
3 months ago
Abcam plc: FY2024 Guidance
Abcam
The Company is providing the following guidance for FY2024. Reported revenue of approximately £475 million to £525 million 1 , representing 11.3% to 13.4% CER...
4 months ago
MAPK signaling pathway
Abcam
MAPK signaling pathway. Mitogen-activated protein kinase (MAPK) cascades consist of at least three protein kinase modules that are sequentially...
2 months ago
Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb® antibodies
Abcam
Partnership extends Abcam's reach within in vitro diagnostics market ... Under the agreement, Cell Marque will apply its extensive IVD expertise to incorporate...
4 months ago
Abcam opens new US facility in Boston, MA
Abcam
Abcam opens new US facility in Boston, MA ... Cambridge, UK, 13 July 2021 – Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools,...
4 months ago
Apoptosis antibodies: Tools for cell death detection
Abcam
Apoptosis markers can serve as valuable indicators for therapeutic interventions and regulating them can help restore the balance between cell survival and...
5 months ago
Trading update, first quarter 2023
Abcam
The Company is reiterating its 2024 reported revenue goals of £450 million to £525 million<sup>1</sup> with adjusted operating profit margins of greater than 30%. About...
3 months ago